p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice

Current Biology

Volumn 8, Issue 8, 1998, Pages 467-470

  Zornig, Martin ^a   Hueber, Anne Odile ^a   Evan, Gerard ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUS MUSCULUS;

EID: 0032499138     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(98)70182-4     Document Type: Article

References (19)

1. Wallach D, Boldin M, Goncharov T, Golstev Y, Mett I, Malinin N, et al.: Exploring cell death mechanisms by analyzing signaling cascades of the TNF/NGF receptor family. Behring Inst Mitt 1996, 97:144-155.
2. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995, 270:7795-7798.
3. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505-512.
4. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995, 81:495-504.
5. Boldin MP, Goncharov TM, Golstev YV, Wallach D: Involvement of MACH, a novel MORT1/ FADD-interacting protease, in Fas/APO-1-and TNF receptor induced cell death. Cell 1996, 85:803-815.
6. Muzio M, Chinnaiyan AM, Kischel FC, O'Rourke K, Shevchenko A, Ni J, et al.: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996, 85:817-827.
7. Adachi M, Suematsu S, KondoT, Ogasawara J, Tanaka T, Yoshida N, Nagata S: Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 1995, 11:294-300.
8. Pfeffer K, Matsuyama T, Kündig TM, Wakeham A, Kishihara K, Shahinian A, et al.: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73:457-467.
9. Rothe JW, Lesslauer H, Lötscher H, Lang Y, Koebel P, Königen F, et al.: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993, 364:798-802.
10. Swan KA, Alberola-lla J, Gross JA, Appleby MW, Forbush KA, Thomas JF, Perlmutter RM: Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J 1995, 14:276-285.
11. Aggarwal BB, Singh S, LaPushin R, Totpal K: Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett 1995, 364:5-8.
12. Anderson DM, Maraskovsky E, Billingsley W, Dougall W, Tometsko ME, Roux E, et al.: A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic cell function. Nature 1997, 390:175-179.
13. Golstein P: Cell death: TRAIL and its receptors. Curr Biol 1997, 7:R750-R753.
14. Wajant H, Johannes FJ, Haas E, Siemienski K, Schwenzer S, Schubert G, et al.: Dominant-negative FADD inhibits TNFR-60-, Fas/APO1-and TRAIL-R/APO2-mediated cell death but not gene induction. Curr Biol 1998, 8:113-116.
15. Yang X, Khosravi-Far R, Chang H, Baltimore D: Daxx, a novel Fasbinding protein that activates JNK and apoptosis. Cell 1997, 89:1067-1076.
16. Newton K, Harris AW, Bath ML, Smith KGC, Strasser A: A dominant interfering mutant of FADD/MORT enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 1998, 17:706-718.
17. Lloyd A, Obermüller F, Staddon S, Earth C, McMahon M, Land H: Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 1997, 11:663-677.
18. Serrano M, Lin A, McCurrach M, Beach D, Lowe S: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
19. Lucas B, Vasseur F, Penit C: Normal sequence of phenotypic transitions in one cohort of 5-bromo-2′·-deoxyuridine-pulse-labeled thymocytes. J Immunol 1998, 151:4574-4582.